InMed Pharmaceuticals (INM) Share-based Compensation (2019 - 2026)
InMed Pharmaceuticals (INM) posted Share-based Compensation of $186098.0 for Q1 2026, down 5.32% on a QoQ basis from $196561.0 in Q4 2025, and up 200.82% year-over-year from $61864.0 in Q1 2025.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Share-based Compensation (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals has reported Share-based Compensation for 8 years, with the latest figure at $186098.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 200.82% year-over-year to $186098.0 in Q1 2026; TTM through Mar 2026 was $186098.0, a 200.82% increase from a year earlier, with the FY2025 full-year figure at $72549.0, down 92.51% from the prior year.
- Share-based Compensation was $186098.0 for Q1 2026 at InMed Pharmaceuticals, down from $196561.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.5 million in Q2 2022, with the low at -$63613.0 in Q2 2025.
- Average Share-based Compensation over 5 years is $300766.6, with a median of $86385.5 recorded in 2022.
- The largest YoY upside for Share-based Compensation was 1247.33% in 2024 against a maximum downside of 128.36% in 2024.
- Over 5 years, Share-based Compensation stood at $70638.0 in 2022, then soared by 794.26% to $631685.0 in 2023, then plunged by 90.12% to $62416.0 in 2024, then soared by 214.92% to $196561.0 in 2025, then fell by 5.32% to $186098.0 in 2026.
- The last three Share-based Compensation figures came in at $186098.0 (Q1 2026), $196561.0 (Q4 2025), and $60356.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.18 Bn | 142.67 Bn | 1.63 Bn | 164.00 Mn |
| 2 | Ati | 28.28 Bn | 27.50 Bn | 309.80 Mn | 7.70 Mn |
| 3 | Qnity Electronics | 26.28 Bn | 25.32 Bn | 666.00 Mn | 14.00 Mn |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | 35.00 Mn |
| 5 | DuPont de Nemours | 17.40 Bn | 15.66 Bn | 639.00 Mn | 11.00 Mn |
| 6 | Avery Dennison | 12.97 Bn | 12.74 Bn | 729.40 Mn | 3.00 Mn |
| 7 | Solstice Advanced Materials | 10.03 Bn | 9.28 Bn | 370.00 Mn | -10.00 Mn |
| 8 | Element Solutions | 8.73 Bn | 8.54 Bn | 334.00 Mn | 12.60 Mn |
| 9 | Eastman Chemical | 7.82 Bn | 7.13 Bn | 560.00 Mn | - |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | 186,098.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 186,098.00 |
| Dec 31, 2025 | 196,561.00 |
| Sep 30, 2025 | 60,356.00 |
| Jun 30, 2025 | -63,613.00 |
| Mar 31, 2025 | 61,864.00 |
| Dec 31, 2024 | 62,416.00 |
| Sep 30, 2024 | -28,964.00 |
| Mar 31, 2024 | 678,475.00 |
| Dec 31, 2023 | 631,685.00 |
| Sep 30, 2023 | 102,133.00 |
| Jun 30, 2023 | 1.00 |
| Mar 31, 2023 | 50,357.00 |
| Dec 31, 2022 | 70,638.00 |
| Sep 30, 2022 | 116,680.00 |
| Jun 30, 2022 | 2.49 Mn |
| Mar 31, 2022 | 195,085.00 |
| Dec 31, 2021 | 214,779.00 |
| Sep 30, 2021 | 111,142.00 |
| Jun 30, 2021 | 220,850.00 |
| Mar 31, 2021 | 207,302.00 |